Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CLL
CLL
Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.
Fierce Pharma
Mon, 01/22/18 - 05:41 pm
Novartis
Arzerra
Genmab
CLL
chronic lymphocytic leukemia
#ASH17: Late breaker from AbbVie, Roche highlights a blockbuster breakout opportunity for Venclexta in CLL
Endpoints
Fri, 11/24/17 - 09:25 am
ASH
AbbVie
Roche
Venclexta
CLL
chronic lymphocytic leukemia
FDA says yes to rapid-acting Rituxan
BioPharma Dive
Fri, 06/23/17 - 11:23 am
FDA
Roche
Rituxan Hycela
refractory follicular lymphoma
CLL
diffuse large B-cell lymphoma
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
Endpoints
Mon, 03/6/17 - 09:47 am
TG Therapeutics
ublituximab
TG-1101
FDA
CLL
AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug
Market Realist
Tue, 11/29/16 - 09:46 am
AbbVie
Imbruvica
oncology
CLL
JNJ's Expensive Leukemia Drug Wins British Nod
Investopedia
Sun, 11/27/16 - 03:54 pm
JNJ
UK
Imbruvica
chronic lymphocytic leukemia
CLL
Roche, AbbVie: Venclyxto Receives Positive Opinion From Committee
Yahoo/GuruFocus
Sat, 10/15/16 - 12:23 pm
Roche
AbbVie
Venclyxto
CHMP
chronic lymphocytic leukemia
CLL
venetoclax
AbbVie Builds Upon Robust Body of IMBRUVICA® (ibrutinib) Data with Phase 3 Longer-Term Studies in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Yahoo
Mon, 06/6/16 - 11:23 am
AbbVie
Imbruvica
CLL
small lymphocytic lymphoma
ASCO 2016
Updated survival data added to Imbruvica's label
BioPharma Dive
Wed, 05/11/16 - 06:41 pm
Imbruvica
CLL
Janssen
AbbVie wins FDA approval for leukemia drug
BioPharma Dive
Mon, 04/11/16 - 05:22 pm
AbbVie
FDA
Venclexta
CLL
Genentech
J&J, AbbVie's Imbruvica breaks into larger CLL market with first-line FDA nod
Fierce Pharma
Sat, 03/5/16 - 09:50 am
JNJ
AbbVie
Imbruvica
CLL
FDA
chronic lymphocytic leukemia
Will This Study Finally Catapult Gilead Sciences Into a Cancer Powerhouse?
Motley Fool
Thu, 12/10/15 - 10:39 am
Gilead Sciences
Zydelig
CLL
chronic lymphocytic leukemia
Can new PhIII data help Gilead's Zydelig stage a comeback in CLL?
Fierce Pharma Marketing
Wed, 12/9/15 - 11:36 am
Gilead Sciences
Zydelig
chronic lymphocytic leukemia
CLL
U.K. cost gatekeeper gives thumbs-up to Gilead's Zydelig for CLL
Fierce Pharma
Thu, 09/24/15 - 11:50 am
UK
Gilead Sciences
Zydelig
CLL
chronic lymphocytic leukemia
AbbVie edges closer to Imbruvica deal payoff with another FDA filing
Fierce Pharma
Tue, 09/15/15 - 03:16 pm
AbbVie
Imbruvica
FDA
JNJ
CLL
chronic lymphocytic leukemia
Novartis team tracks remissions of 4-plus years in a pioneering CAR-T study
Fierce Biotech
Thu, 09/3/15 - 08:40 am
Novartis
CAR-T
CTL019
CLL
chronic lymphocytic leukemia
AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche
Bidness, ETC
Thu, 08/20/15 - 11:53 am
AbbVie
priority review
Roche
CLL
chronic lymphocytic leukemia
United Therapeutics
AbbVie Inc Cancer Drug Holds Blockbuster Potential
Bidness, ETC
Wed, 08/12/15 - 10:11 pm
AbbVie
CLL
Roche
venetoclax
AbbVie to seek FDA approval for leukemia drug after trial success
Yahoo/Reuters
Wed, 08/12/15 - 10:35 am
AbbVie
FDA
Roche
chronic lymphocytic leukemia
CLL
venetoclax
Novartis files leukemia drug Arzerra in the EU
BioPharma Dive
Thu, 07/9/15 - 07:42 pm
Novartis
Arzerra
Europe
Genmab
CLL
chronic lymphocytic leukemia
Pages
« first
‹ previous
1
2
3
4
next ›
last »